ipilimumab
bms
['melanoma', 'lba3', 'ipilimumab']
#esmo22 presidential symposium 1 lba3 til vs ipilimumab for advanced melanoma, phase 3 study 
CME experts Sara Fagerlie, PhD, CHCP & Mindy Tanzola, PhD have joined forces at Front Row to help clinicians & educators manage the oncology information deluge